Cargando…

Identifying early adopters of COVID-19 vaccines in Latin America

COVID-19 vaccine hesitancy is currently-one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important to identify sources of variation so that policies can be tailored to different population groups. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrieta, Alejandro, García-Prado, Ariadna, Sarmiento, Juan Pablo, Paz Castro, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584855/
https://www.ncbi.nlm.nih.gov/pubmed/36328886
http://dx.doi.org/10.1016/j.vaccine.2022.10.033
_version_ 1784813366584279040
author Arrieta, Alejandro
García-Prado, Ariadna
Sarmiento, Juan Pablo
Paz Castro, Carmen
author_facet Arrieta, Alejandro
García-Prado, Ariadna
Sarmiento, Juan Pablo
Paz Castro, Carmen
author_sort Arrieta, Alejandro
collection PubMed
description COVID-19 vaccine hesitancy is currently-one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important to identify sources of variation so that policies can be tailored to different population groups. In this paper, we analyze the results from a survey designed and implemented in order to identify early adopters and laggers in six big cities located in Argentina, Colombia, Chile, Ecuador, Peru, and Dominican Republic. We find that trust in government and science, accurate knowledge about the value of vaccination and vaccine effects, and perceived risk of getting sick is associated with a higher probability to get vaccinated. We also identify potential laggers such as women and populations with high education but low knowledge about vaccines. We discuss specific strategies to promote vaccination among these populations groups as well as more general strategies designed to gain trust. These findings are specific to the context of Latin America insofar as the underlying factors associated with the choice to be vaccinated vary significantly by location and in relation to individual-level factors.
format Online
Article
Text
id pubmed-9584855
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95848552022-10-21 Identifying early adopters of COVID-19 vaccines in Latin America Arrieta, Alejandro García-Prado, Ariadna Sarmiento, Juan Pablo Paz Castro, Carmen Vaccine Article COVID-19 vaccine hesitancy is currently-one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important to identify sources of variation so that policies can be tailored to different population groups. In this paper, we analyze the results from a survey designed and implemented in order to identify early adopters and laggers in six big cities located in Argentina, Colombia, Chile, Ecuador, Peru, and Dominican Republic. We find that trust in government and science, accurate knowledge about the value of vaccination and vaccine effects, and perceived risk of getting sick is associated with a higher probability to get vaccinated. We also identify potential laggers such as women and populations with high education but low knowledge about vaccines. We discuss specific strategies to promote vaccination among these populations groups as well as more general strategies designed to gain trust. These findings are specific to the context of Latin America insofar as the underlying factors associated with the choice to be vaccinated vary significantly by location and in relation to individual-level factors. Elsevier Ltd. 2022-11-22 2022-10-21 /pmc/articles/PMC9584855/ /pubmed/36328886 http://dx.doi.org/10.1016/j.vaccine.2022.10.033 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Arrieta, Alejandro
García-Prado, Ariadna
Sarmiento, Juan Pablo
Paz Castro, Carmen
Identifying early adopters of COVID-19 vaccines in Latin America
title Identifying early adopters of COVID-19 vaccines in Latin America
title_full Identifying early adopters of COVID-19 vaccines in Latin America
title_fullStr Identifying early adopters of COVID-19 vaccines in Latin America
title_full_unstemmed Identifying early adopters of COVID-19 vaccines in Latin America
title_short Identifying early adopters of COVID-19 vaccines in Latin America
title_sort identifying early adopters of covid-19 vaccines in latin america
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584855/
https://www.ncbi.nlm.nih.gov/pubmed/36328886
http://dx.doi.org/10.1016/j.vaccine.2022.10.033
work_keys_str_mv AT arrietaalejandro identifyingearlyadoptersofcovid19vaccinesinlatinamerica
AT garciapradoariadna identifyingearlyadoptersofcovid19vaccinesinlatinamerica
AT sarmientojuanpablo identifyingearlyadoptersofcovid19vaccinesinlatinamerica
AT pazcastrocarmen identifyingearlyadoptersofcovid19vaccinesinlatinamerica